The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...

Peter Thiel-backed biotech developer AbCellera Biologics Inc, which has partnered with Eli Lilly for its COVID-19 antibody drug, said on Monday it expects to raise up to $391 million in its initial ...

Biotechnology and biomanufacturing are witnessing a transformative shift with the rise of chassis cells. Serving as the cornerstone of modern ...

The deal will bolster BMS's cell therapy efforts by adding Orbital's lead program in autoimmune diseases and RNA platform to its portfolio.

TIME Magazine announces its Top 300 Best Inventions of 2025 (one North Vancouver company recognized) Vancouver, BC, October ...